XTalks

JUNE 1, 2023

Univar Solutions , a leading global distributor of ingredients and chemicals, has recently been chosen to distribute ICL’s Rovitaris line of textured plant proteins in North America. The company prides itself on its relentless drive to continually develop and refine products that fill existing gaps in the market.

Protein 98

Protein Production Development Marketing 98

XTalks

JULY 26, 2023

Brevel , an Israeli startup specializing in the conversion of microalgae into alternative proteins, recently secured $18.5 The Tel Aviv-based startup will use the new funding to deliver an alternative protein source that is neutral in taste, highly functional, remarkably sustainable and accessible to the broader food industry.

Protein 97

Protein Production Cosmetics Marketing 97

Pharmaceutical Technology

JULY 21, 2022

It also received an orphan medicinal product designation from the European Commission (EC) to treat MDS in the EU. The EC designation comes after the Committee for Orphan Medicinal Products (COMP) provided an opinion on the designation. MDS are a group of diseases characterised by ineffective blood component production.

Clinical Trials 264

Clinical Trials Clinical Trials Protein Production 264

Pharmaceutical Technology

SEPTEMBER 14, 2022

API peptides and proteins-based drugs have gained much attention in the past decade. Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. Discover the top API protein and peptide companies in contract marketing. Technologies in the delivery of peptides and proteins.

Protein 100

Protein Marketing Manufacturing Reagent 100

Fierce Pharma

NOVEMBER 8, 2024

With biomanufacturing often a limiting factor for drug developers, Canada’s Future Fields is heralding its bug-based approach to protein production as a potential salve.

Protein 72

Protein Production Manufacturing Development 72

Medical Xpress

APRIL 21, 2023

A new publication released today in The EMBO Journal identified a key protein in the molecular mechanism triggering neurogenesis in the hippocampus. They found that tight regulation of Yap1 activity is essential as dysregulation can cause tissue disruption seen in the early stages of brain cancer.

Protein 102

Protein Production Regulation Research 102

Pharmaceutical Technology

MAY 30, 2023

SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion, a protein-based vaccine created in collaboration with GSK’s pandemic adjuvant, is suitable for storage between 2° and 8° Celsius.

Vaccination 298

Vaccination Vaccine Protein Medicine 298

Pharmaceutical Technology

MAY 17, 2023

Antisense therapies are designed for destroying mRNA, reducing the amount of disease-causing protein. They will also have the potential to treat diseases that are caused by too little protein by increasing production, thus restoring the protein to normal levels.

Development 246

Development Protein RNA Genetics 246

Pharmaceutical Technology

APRIL 6, 2023

Biotheryx and Incyte have signed an agreement for identifying and developing targeted protein degraders for historically undruggable oncology targets. Biotheryx will also receive up to $347m in potential future regulatory and commercial milestone payments, along with tiered single-digit royalties on net product sales across the globe.

Protein 130

Protein Development Sales Production 130

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Drugs 295

Drugs Gene Therapy Production Manufacturing 295

Pharmaceutical Technology

MAY 9, 2023

The companies will use the natural product discovery capabilities of Ginkgo Bioworks to expedite the discovery and development of new therapeutic molecules to address diseases with high unmet patient needs.

Development 261

Development Protein Sales Production 261

Pharmaceutical Technology

JUNE 24, 2022

The protein-based vaccine is engineered from the genetic sequence of the SARS-CoV-2 virus’ initial strain. Developed utilising Novavax’s recombinant nanoparticle technology to generate antigen obtained from the coronavirus spike (S) protein, the vaccine is also formulated with the company’s saponin-based Matrix-M adjuvant. “As

Vaccination 263

Vaccination Vaccine Clinical Trials Clinical Trials 263

Pharmaceutical Technology

MARCH 5, 2025

coli expression system, EffiX, designed to enhance the production of recombinant proteins and pDNA. WuXi Biologics has launched the E.

Protein 147

Protein Production 147

Pharmaceutical Technology

SEPTEMBER 7, 2022

A recombinant replication-deficient adenovirus vectored vaccine, iNCOVACC has a prefusion stabilised spike protein and is claimed to be the first intranasal vaccine globally to obtain primary two-dose schedule approvals. It is formulated to permit intranasal delivery via nasal drops.

Vaccination 263

Vaccination Vaccine Clinical Trials Clinical Trials 263

Pharmaceutical Technology

JULY 6, 2022

A protein-based vaccine, NVX-CoV2373 is made from the genetic sequence of the SARS-CoV-2 virus’ first strain. The latest development comes after the Committee for Medicinal Products for Human Use of the European Medicines Agency granted a positive recommendation in June this year.

Vaccination 264

Vaccination Vaccine Protein Clinical Trials 264

XTalks

DECEMBER 10, 2024

Rilzabrutinib joins a wave of innovative ITP therapies , including thrombopoietin-receptor agonists like eltrombopag and romiplostim, which boost platelet production. Rilzabrutinib works by targeting BTK, a protein involved in immune cell communication.

Trials 104

Trials Protein Clinical Development Drugs 104

Bio Pharma Dive

JANUARY 29, 2024

A successor medicine to Sarepta's Exondys 51 appeared better at boosting dystrophin protein production, but was associated with electrolyte imbalances.

Protein 154

Protein Medicine Production 154

Pharmaceutical Technology

SEPTEMBER 5, 2022

The National Medical Products Administration of China (NMPA) has approved CanSino Biologics ’ (CanSinoBIO) recombinant Covid-19 vaccine (Adenovirus Type 5 Vector) for inhalation, Convidecia Air, as a booster. This vaccine leverages the same adenovirus vector technological platform as Convidecia, the intramuscular version.

Vaccination 264

Vaccination Vaccine Genetic Engineering Clinical Trials 264

Pharmaceutical Technology

APRIL 21, 2023

In return, Twist is entitled to receive an upfront payment along with annual maintenance fees, as well as fees per product, subject to the accomplishment of specific clinical and commercial milestones. The company is also expected to receive royalty payments on sales of the product.

Antibody 264

Antibody Licensing Licensing Protein 264

XTalks

JUNE 8, 2023

Ever After Foods’ unique breakthrough lies in its proprietary bioreactor setup, which has the potential to tackle the central challenge of escalating cultivated meat production. Recent research suggests that cultivated meat is more sustainable than traditional animal products, especially when coupled with renewable energy use.

Production 98

Production Protein Marketing Branding 98

XTalks

JANUARY 3, 2024

As we step into 2024, the food industry is buzzing with the introduction of innovative new food products. These high-protein, low-sugar bars offer a portable and keto-friendly snack option. This year is poised to be an exciting year for food enthusiasts, with these innovative new food products hitting the shelves.

Production 103

Production Protein Hormones Packaging 103

XTalks

MARCH 31, 2023

By growing high quality crystal structures of protein-based therapeutics under microgravity, researchers can gain better insights into their complex structures and stability. The proteins will be analyzed back on Earth using techniques such as X-ray diffraction and compared with crystals from the same biologics grown on Earth.

Protein 97

Protein Research Development Manufacturing 97

World of DTC Marketing

DECEMBER 29, 2020

First, a novel approach was used that didn’t require traditional vaccine production in cell cultures or eggs. Once introduced into the human body, the protein-making machinery uses this genetic material in our cells to churn out the coronavirus “spike protein,” triggering an immune response.

Vaccination 307

Vaccination Vaccine Development Clinical Trials 307

Pharmaceutical Technology

APRIL 22, 2024

Develop a stable cell line for high-titer rAAV production with Ultragenyx's patented method involving HDAC inhibitors and AAV rep proteins. Explore the groundbreaking patent now!

Development 130

Development Protein Production 130

Medical Xpress

JANUARY 4, 2023

The researchers found no differences in antibody production, auto-antibodies, T cell profiles, or prior viral exposures, but found elevated levels of spike protein along with increased cytokines (consistent with innate inflammation) and increased troponin (indicating cardiac injury).

Immune Response 97

Immune Response Protein Vaccination Vaccine 97

Pharmaceutical Technology

MARCH 11, 2024

Market-leading HCP analysis, as well as other process-related impurity analysis, is becoming smoother

Protein 100

Protein Production Marketing 100

Pharmaceutical Technology

DECEMBER 23, 2022

As per the prior and expanded agreements, ProQR is entitled to get research, development and commercialisation milestone payments totalling up to nearly $3.75bn, apart from tiered royalty payments on sales of products. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Genetics 328

Genetics Medicine Development Gene Therapy 328

BioPharma Reporter

JANUARY 24, 2023

CDMO AGC Biologics will produce Tzield (teplizumab-mzwv), a recently-approved T1D treatment from Provention Bio, at its Seattle protein biologics manufacturing site.

Production 97

Production Protein Manufacturing 97

XTalks

SEPTEMBER 7, 2023

She gives examples of other products for lactose intolerance on the market, including Lactaid and Almond Breeze, but explains why Intoleran is different. The team commends this company for creating an innovative product that allows those with lactose intolerance to enjoy baked goods without sacrifices.

Production 105

Production Marketing Branding Protein 105

Pharmaceutical Technology

MARCH 10, 2023

In an email to Pharmaceutical Technology , an NHSBT spokesperson said the centre will “support early phase clinical trials and preclinical work, providing a route to eventual commercial scale production”. The NHSBT representative explained that a lack of manufacturing spaces led to delays in production slots for many gene therapy developers.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

Medical Xpress

FEBRUARY 22, 2023

The results are reported in an article published in the journal Probiotics and Antimicrobial Proteins. A daily dose of a strain of brewer's yeast used to produce cachaça (distilled spirit made from fermented sugarcane juice) can act as a preventive against asthma, according to a Brazilian study involving male mice.

Production 98

Production Protein Research 98

Pharmaceutical Technology

DECEMBER 8, 2022

The delivery of the product is anticipated to begin early next year. Directed against a cell membrane protein called CD19, Yescarta uses the immune system of the patient to destroy cancer.

Licensing 305

Licensing Licensing Gene Therapy Gene 305

Pharmaceutical Technology

JUNE 21, 2023

In the past year, Hemgenix has been granted approval by the US Food and Drug Administration (FDA) and has received conditional marketing authorisation from the European Commission (EC) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891).

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

Pharmaceutical Technology

SEPTEMBER 2, 2022

A group of ailments, haemoglobinopathies is associated with an irregular production or structure of the haemoglobin protein in the red blood cells. The deal is in line with the company’s strategy to complement and expedite its scientific presence and pipeline in haemoglobinopathies.

Clinical Trials 264

Clinical Trials Clinical Trials Protein Trials 264

XTalks

FEBRUARY 5, 2025

The FDAs decision was based on comprehensive data demonstrating biosimilarity between Avtozma and the reference product, Actemra. Avtozma will be available in the same formulations and dosages as the reference product. It also has EUA for children aged between two and 18. The SC injection comes in 162 mg/0.9

FDA Approval 102

FDA Approval Marketing Antibody Immune Response 102

Pharmaceutical Technology

NOVEMBER 14, 2022

binding antibody, a cell-surface protein which is greatly expressed in ovarian cancer, as well as the maytansinoid payload DM4. Elahere obtained the approval based on the findings on objective response rate (ORR) and duration of response (DOR) reported in the SORAYA clinical trial. The ADC comprises an FR?-binding

Antibody 246

Antibody FDA Approval Clinical Trials Clinical Trials 246

Pharmaceutical Technology

JULY 12, 2022

A protein-based vaccine, NVX-CoV2373 is created from the genetic sequence of the SARS-CoV-2 virus’ initial strain. It is formulated with the company’s saponin-based Matrix-M and also comprises a purified protein antigen. Presently, the EUA application for the vaccine submitted by the company is being reviewed by the FDA.

Vaccination 162

Vaccination Vaccine Protein Pharmacy 162